Fritextsökning
Innehållstyper
-
Fortsatt fokus på kliniska studier
Diamyds förlust minskar och bolaget ser fram emot att presentera resultaten från sina kliniska prövningar.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Danish biorefinery can save US billions
The Danish Inbicon biorefinery process could save the US billions on foreign oil, the organization states.
-
Will the industry follow the economic revival?
Welcome to the eleventh Biotech Forum + Scanlab Fair!
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
Biotech dippar i börskrisen
De senaste månaderna har varit minst sagt turbulenta på börsen. De stora bolagen står starka medan högriskbolag i tidiga forskningsfaser ligger en bra bit under index.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
Infidelity produces faster sperms
Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.
-
Anyara verksam i subgrupp
Nya analyser visar att Active Biotechs läkemedelskandidat mot njurcancer, Anyara, gav statistisk signifikans i en subgrupp. I slutet av maj presenteras de nya d...
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Take off for this year's fair
More visitors than previously were preregistered when Scanlab and Biotech Forum opened today. But the future of the exhibitions and their design is uncertain.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Nordic Life Science Days slog i taket
Nästan 900 besökare från 26 länder besökte Nordic Life Science Days 2014 för att nätverka med den nordiska life science-branschen.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
High hopes for future partnering - the solution for struggling fairs
Business fairs are struggling but the concept of partnering is hotter than ever. By using social media, participants can prepare themselves for the perfect meeting.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
Danmark i forskartoppen
Nordiska forskare citeras mer än världsgenomsnittet. Danskarna citeras hela 40 gånger mer.
-
How to get visitors to your booth
Food, ball throwing and laser engraved pens. There are many tricks to attract visitors to the stands at Scanlab.
-
Europas enda bantningsmedel får grönt ljus efter granskning
EMA anser att nyttan överväger risken vad gäller läkemedel som baseras på orlistat.
-
Almedalen: bilderna, åsikterna, människorna
Bland runstenar och fornlämningar diskuterades AI, framtidens IT-system i vården och hur modern medicinteknik kan hjälpa människor på liv och död. En talande mi...
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...
-
Nya genregioner bakom fetma
En forskargrupp, delvis ledd av forskare vid Karolinska Institutet, presenterar 32 genregioner som kan kopplas till fetma i senaste numret av Nature Genetics.